0001144204-16-120327.txt : 20160819
0001144204-16-120327.hdr.sgml : 20160819
20160819140647
ACCESSION NUMBER: 0001144204-16-120327
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160819
DATE AS OF CHANGE: 20160819
EFFECTIVENESS DATE: 20160819
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aridis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001614067
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320074500
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-269256
FILM NUMBER: 161842780
BUSINESS ADDRESS:
STREET 1: 5941 OPTICAL COURT
CITY: SAN JOSE
STATE: CA
ZIP: 95138
BUSINESS PHONE: (408) 385-1742
MAIL ADDRESS:
STREET 1: 5941 OPTICAL COURT
CITY: SAN JOSE
STATE: CA
ZIP: 95138
D
1
primary_doc.xml
X0707
D
LIVE
0001614067
Aridis Pharmaceuticals, Inc.
5941 OPTICAL COURT
SAN JOSE
CA
CALIFORNIA
95138
(408) 385-1742
DELAWARE
Aridis Pharmaceuticals LLC
None
Corporation
true
Vu
Truong
5941 Optical Court
San Jose
CA
CALIFORNIA
95138
Executive Officer
Director
Chief Executive Officer, Director
Eric
Patzer
5941 Optical Court
San Jose
CA
CALIFORNIA
95138
Executive Officer
Director
Secretary, Chairman of the Board of Directors
Fred
Kurland
5941 Optical Court
San Jose
CA
CALIFORNIA
95138
Executive Officer
Chief Financial Officer
Paul-Andre
de Lame
5941 Optical Court
San Jose
CA
CALIFORNIA
95138
Executive Officer
Chief Medical Officer
Robert
K.
Coughlin
5941 Optical Court
San Jose
CA
CALIFORNIA
95138
Director
Craig
Gibbs
5941 Optical Court
San Jose
CA
CALIFORNIA
95138
Director
John
Hamilton
5941 Optical Court
San Jose
CA
CALIFORNIA
95138
Director
Robert
R.
Ruffolo, Jr.
5941 Optical Court
San Jose
CA
CALIFORNIA
95138
Director
Isaac
Blech
5941 Optical Court
San Jose
CA
CALIFORNIA
95138
Director
Vice Chairman
Pharmaceuticals
Decline to Disclose
- 06b
false
2016-08-12
false
true
true
true
false
50000
Maxim Merchant Capital, a division of Maxim Group LLC
120708
None
None
405 LEXINGTON AVE
NEW YORK
NY
NEW YORK
10174
AZ
ARIZONA
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
DE
DELAWARE
DC
DISTRICT OF COLUMBIA
FL
FLORIDA
HI
HAWAII
IL
ILLINOIS
IN
INDIANA
KS
KANSAS
KY
KENTUCKY
MD
MARYLAND
MA
MASSACHUSETTS
MI
MICHIGAN
MN
MINNESOTA
MO
MISSOURI
NV
NEVADA
NH
NEW HAMPSHIRE
NJ
NEW JERSEY
NY
NEW YORK
PA
PENNSYLVANIA
RI
RHODE ISLAND
SC
SOUTH CAROLINA
TX
TEXAS
VT
VERMONT
WI
WISCONSIN
WY
WYOMING
true
40000000
15216241
24783759
false
133
1521624
0
The placement agent also received a warrant to purchase Series A Convertible Preferred Stock or common stock at the same exercise price as investors.
0
false
Aridis Pharmaceuticals, Inc.
/s/ Vu Truong
Vu Truong
Chief Executive Officer
2016-08-19